Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 257-264

  Mayerhofer, Artur ^a   Hemmings Jr , Hugh C ^b   Snyder, Gretchen L ^c   Greengard, Paul ^c   Boddien, Sylvia ^a   Berg, Ulrike ^d   Brucker, Cosima ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; ESTRADIOL; MESSENGER RNA; NORADRENALIN; PHOSPHOPROTEIN DARPP 32; PROGESTERONE;

ARTICLE; FEMALE; GENE EXPRESSION; GRANULOSA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUTEAL CELL; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS;

ADULT; BASE SEQUENCE; CELLS, CULTURED; CYCLIC AMP; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ESTRADIOL; FEMALE; GRANULOSA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; OVARY; PHOSPHOPROTEINS; PHOSPHORYLATION; PROGESTERONE; RECEPTORS, DOPAMINE D1; RNA, MESSENGER;

EUKARYOTA; FALLOPIA;

EID: 0032932676     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.257     Document Type: Article

References (50)

1. 1. Spicer LJ. 1986 Catecholaminergic regulation of ovarian function in mammals: current concepts. Life Sci. 39:1701-1711.
2. 2. Kawakami M, Kubo K, Uemura T, Nagase M, Hayashi R. 1981 Involvement of ovarian innervation in steroid secretion. Endocrinology. 109:136-145.
3. 3. Sjöberg N-O, Hamberger L, Janson PO, Owman CH, Coelingh-Bennink HJT, eds. 1992 Local regulation of ovarian function. Park Ridge,: Panthenon Publishing Group.
4. 4. Ojeda SR, Lara HE. 1989 Role of the sympathetic nervous system in the regulation of ovarian function. In: Rirke KM, Wuttke W, Schweiger U, eds. The menstrual cyle and its disorders. Berlin: Springer-Verlag; 26-32.
5. 5. Ojeda SR, Mayerhofer A, Dissen GA, Hill DF, Smith GD, Wolf DP, Dees WL, Skinner MK. 1996 Ovarian development is influenced by a neuroendocrinotrophic regulatory complex. In: Filicori M, Flamigni C, eds. The ovary: regulation, dysfunction, and treatment. Amsterdam: Elsevier Science; 51-59.
6. 6. Trafriri A, Adashi EY. 1994 Local nonsteroidal regulators of ovarian function. In: Knobil E, Neill JD, et al., eds. The physiology of reproduction. 2nd ed. New York: Raven Press; 817-860.
7. 7. Adashi EY. 1992 The potential relevance of cytokines to ovarian physiology. J Steroid Biochem Mol Biol. 43:439-444.
8. 8. Föhr KF, Mayerhofer A, Sterzik K, Rudolf M, Rosenbusch B, Gratzl M. 1993 Concerted action of human chorionic gonadotropin and norepinephrine on intracellular free calcium in human granulosa-lutein cells: evidence for the presence of a functional alpha-adrenergic receptor. J Clin Endocrinol Metab. 76:367-373.
9. 9. Lara HE, Dees WL, Hiney JK, Dissen GA, Rivier C, Ojeda SR. 1991 Functional recovery of the developing rat ovary after transplantation: contribution of the extrinsic innervation. Endocrinology. 129:1849-1860.
10. 10. Lara HE, Ferruz JL, Luza S, Bustameente DA, Borges Y, Ojeda SR. 1993 Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology. 133:2690-2695.
11. 11. Mayerhofer A, Dissen GA, Costa ME, Ojeda SR. 1997 A role for neurotransmitters in early follicular development: induction of functional FSH receptors in newly formed follicles. Endocrinology. 138:3320-3329.
12. 12. Laurence JR IE, Burden HE. 1980 The origin of the extrinsic adrenergic innervation to the rat ovary. Anat Rec. 196:51-59.
13. 13. Dees WL, Hiney JK, Schultea TD, et al. 1995 The primate ovary contains a population of catecholaminergic neuron-like cells expressing nerve growth factor receptors. Endocrinology. 136:5760-5768.
14. 14. Mayerhofer A, Danilchik M, Lara H, Pau F, Russell LD, Ojeda SR. 1996 Testis of prepubertal rhesus monkeys receives a dual catecholaminergic input provided by the extrinsic and an intragonadal source of catecholamines. Biol Reprod. 55:509-518.
15. 15. Mayerhofer A, Dissen GA, Pau KY, Ojeda SR. 1994 Novel tyrosine hydroxylase mRNA forms in rhesus monkey testis and ovary. Soc Neurosci Abstr. 20, Part 1:11.
16. 16. Bahr J, Ben-Jonathan N. 1985 Elevated catecholamines in porcine follicular fluid before ovulation. Endocrinology. 177:620-623.
17. 17. Femadez-Pardal J, Gimeno MF, Gimeno AL. 1986 Catecholamines in sow graafian follicles at proestrus and at diestrus. Biol Reprod. 34:439-445.
18. 18. Bodis J, Hartmann G, Török A, et al. 1993 Relationship between the monoamine and gonadotropin content in follicular fluid of preovulatory graafian follicles after superovulation treatment. Exp Clin Endocrinol. 101:178-182.
19. 19. Kotwica J, Skarzynski D, Bogacki M, Miszkiel G. 1996 Influence of dopamine as noradrenaline precursor on the secretory function of the bovine corpus luteum in vitro. Br J Pharmacol. 118:1669-1674.
20. 20. Bodis J, Tinneberg HR, Török A, Cledon P, Hanf V, Papenfuss F. 1993 Effect of noradrenaline and dopamine on progesterone and estradiol secretion of human granulosa cells. Acta Endocrinol (Copenh). 129:165-168.
21. 21. Mori H, Arakawa S, Ohkawa T, et al. 1994 The involvement of dopamine in the regulation of steroidogenesis in rat ovarian cells. Horm Res. [Suppl 1] 41:36-40.
22. 22. Mayerhofer A, Föhr KJ, Sterzik K, Gratzl M. 1992 Carbachol increases intracellular free calcium concentrations in human granulosa-lutein cells in vitro. J Endocrinol. 135:153-159.
23. 23. Mayerhofer A, Sterzik K, Link H, Wiemann M, Gratzl M. 1993 Oxytocin increases intracellular tree calcium concentrations in human granulosa-lutein cells in vitro. J Clin Endocrinol Metab. 77:1209-1214.
24. 24. Mayerhofer A, Lahr G, Fröhlich U, Zienecker R, Sterzik K, Gratzl M. 1994 Expression and alternative splicing of the neural cell adhesion molecule NCAM in human granulosa cell during luteinization. FEBS Lett. 346:207-212.
25. 25. Mayerhofer A, Engling R, Stecher B, Ecker A, Sterzik K, Gratzl M. 1995 Relaxin triggers calcium transients in human granulosa-lutein cells. Eur J Endocrinol. 132:507-513.
26. 26. Pellicier A, Mari M, de los Santos MJ, Simon C, Remohi J, Tarin JJ. 1994 Effects of aging on the human ovary: the secretion of immunoreactive alphainhibin and progesterone. Fertil Steril. 61:663-668.
27. 27. Ma YJ, Costa M, Ojeda SR. 1994 Developmental expression of of the genes encoding transforming growth factor alpha (TGF a) and its receptor in the hypothalamus of female rhesus macaques. Neuroendocrinology. 60:346-359.
28. 28. Sundahara RK, Niznik HB, Weiner DM, et al. 1990 Human D1 receptor encoded by an intronless gene on chromosome 5. Nature. 347:80-83.
29. 29. Kurihara T, Lewis RM, Eisler J, Greengard P. 1988 Cloning of cDNA for DARPP-32, a dopamine-and cyclic AMP-regulated neuronal phosphoprotein. J Neurosci. 8:508-517.
30. 30. Hemmings Jr HC, Greengard P. 1986 DARPP-32, a dopamine-and adenosine 3′,5′-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J Neurosci. 6:1469-1481.
31. 31. Mayerhofer A, Lahr G, Gratzl M. 1991 Expression of the neural cell adhesion molecule (NCAM) in endocrine cells of the ovary. Endocrinology. 129:792-800.
32. 32. Snyder GL, Girault J-A, Chen JYC, et al. 1992 Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1: regulation by factors other than dopamine. J Neurosci. 12:3071-3083.
33. 33. Höhne-Zell B, Gratzl M. 1996 Adrenal chromaffin cells contain functionally different SNAP-25 monomers and SNAP-25/syntaxin heterodimers. FEBS Lett. 394:109-116.
34. 34. Desdouits F, Cohen D, Nairn AC, Greengard P, Girault J-A. 1995 Phosphorylation of DARPP-32, a dopamine-and cAMP-regulated phosphoprotein, by casein kinase I in vitro and in vivo. J Biol Chem. 270:8772-8778.
35. 35. Desdouits F, Siciliano JC, Greengard P, Girault J-A. 1995 b Dopnmine-and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of ser-137by casein kinase I inhibits dephosphorylation of thr-34 by calcineurin. Proc Natl Acad Sci USA. 92:2682-2685.
36. 36. Neve KA, Neve RL, eds. 1997 The dopamine receptors. Totowa, New Jersey: Humana Press.
37. 37. Aherne AM, Vaughan CJ, Carey RM, O'Connell DP. 1997 Localization of dopamine D1A receptor protein and messenger ribonucleic acid in rat adrenal cortex. Endocrinology. 138:1282-1288.
38. 38. Furger C, Pouchelet M, Zorn JR, Ferre F. 1996 Cell shape change reveals the cyclic AMP-mediated action of follicle stimulating hormone, human chorionic gonadotrophin and vasoactive intestinal peptide in primary cultured human granulosa-luteal cells. Mol Hum Reprod. 2:251-257.
39. 39. Brene S, Lindefors N, Ehrlich M, et al. 1994 Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J Neurosci. 14:985-998.
40. 40. Hemmings HC, Nairn AC, Bibb JA, Greengard P. 1995 Signal transduction in the striatum: DARPP-32, a molecular integrator of multiple signaling pathways. In: Ariano MA, Surmeier DJ, eds. Molecular and cellular mechanisms of neostriatal function. Austin, TX: RG Landes Company; 283-297.
41. 41. Blau S, Daly L, Fienberg A, Teitelman G, Ehrlich M. 1995 DARPP-32 promoter directs transgene expression to renal thick ascending limb of Henle. Am J Physiol. 269:F564-F570.
42. 42. Kwon YG, Huang HB, Desdouits F, et al. 1997 Characterization of the interaction between DARPP-32 and protein phosphatase 1 (PP-1): DARPP-32 peptides antagonize the interaction of PP-1 with binding proteins. Proc Natl Acad Sci USA. 94:3536-3541.
43. 43. Wang X, Robinson PJ. 1997 Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem. 68:443-456.
44. 44. Bodis J, Török A, Tinneberg H-R, Hanf V, Hamori M, Cledon P. 1992 Influence of serotonin on progesterone and estradiol secretion of cultured human granulosa cells. Fertil Steril. 57:1008-1011.
45. 45. Flaws JA, DeSanti A, Tilly K, et al. 1995 Vasoactive intestinal peptide-mediated suppression of apoptosis in the ovary: potential mechanism of action and evidence of a conserved antiatretogenic role through evolution. Endocrinology. 136:4351-4359.
46. 46. Suzuki T, Sasano H, Kimura N, et al. 1994 Immunohistochemical distribution of progesterone, androgen and oestrogen receptors in the human ovary during the menstrual cycle: relationship to expression of steroidogenic enzymes. Hum Reprod:1589-1595.
47. 47. Power RF, Mani SK, Codina J, Conneely OM, O'Malley BW. 1991 Dopaminergic and ligand-independent activation of steroid hormone receptors. Science. 254:1636-1639.
48. 48. Mani SK, Allen JMC, Clark JH, Blaustein JD, O'Malley BW. 1994 Convergent pathways for steroid hormone-and neurotransmitter-induced rat sexual behavior. Science. 265:1246-1249.
49. 49. Mayerhofer A, Smith GD, Danilchik M, et al., 1998 Oocytes are a source of catecholamines in the primate ovary: evidence for a novel cell-cell regulatory loop in the ovary. Proc Natl Acad Sci USA. 95:10990-10995.
50. 50. Mezey E, Eisenhofer G, Harta G, et al. 1996 A novel non-neuronal catecholaminergeric system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci USA. 93:10377-10382.